Updates on Responsive Drug Delivery Based on Liposome Vehicles for Cancer Treatment by Maria P. Nikolova, Enamala Manoj Kumar, Murthy S. Chavali

Get full text

Bladder microenvironment actuated proteomotors with ammonia amplification for enhanced cancer treatment by Hao Tian, Juanfeng Ou, Yong Wang, Jia Sun, Junbin Gao, Yicheng Ye, Ruotian Zhang, Bin Chen, Fei Wang, Weichang Huang, Huaan Li, Lu Liu, Chuxiao Shao, Zhili Xu, Fei Peng, Yingfeng Tu

“…We envision that the as-developed swimming proteomotors with amplification of the product toxicity may be a potential platform for active cancer treatment.…”
Get full text

Engineered elastin-like polypeptides: An efficient platform for enhanced cancer treatment by Aiguo Jiang, Xinqiang Guan, Lianping He, Xingang Guan, Xingang Guan

“…In this review, we summarize the recent application of ELPs in cancer treatment, focusing on the delivery of functional peptides, therapeutic proteins, small molecule drugs, and photosensitizers.…”
Get full text

A Promising Review on Cyclodextrin Conjugated Paclitaxel Nanoparticles for Cancer Treatment by Kamini Velhal, Sagar Barage, Arpita Roy, Jaya Lakkakula, Ramesh Yamgar, Mohammed S. Alqahtani, Krishna Kumar Yadav, Yongtae Ahn, Byong-Hun Jeon

“…In addition, the application of cyclodextrins in cancer treatment, which reduces the off-target effects, is briefly demonstrated using various types of cancer cell lines. …”
Get full text

Mucosal Injury during Anti-Cancer Treatment: From Pathobiology to Bedside by Debora Basile, Paola Di Nardo, Carla Corvaja, Silvio Ken Garattini, Giacomo Pelizzari, Camilla Lisanti, Lucia Bortot, Lucia Da Ros, Michele Bartoletti, Matteo Borghi, Lorenzo Gerratana, Davide Lombardi, Fabio Puglisi

Subjects: Get full text

Nanotechnology-Based Biopolymeric Oral Delivery Platforms for Advanced Cancer Treatment by Vanessa T. Chivere, Pierre P. D. Kondiah, Yahya E. Choonara, Viness Pillay

Get full text

Radical Tumor Denervation Activates Potent Local and Global Cancer Treatment by John D. Mitsou, Vivian Tseveleki, Foteinos-Ioannis Dimitrakopoulos, Konstantinos Konstantinidis, Haralabos Kalofonos

Get full text

Hybrid VMAT-3DCRT as breast cancer treatment improvement tool by Cyril Voyant, Morgane Pinpin, Delphine Leschi, Séverine Prapant, Françoise Savigny, Marie-Aimée Acquaviva

Get full text

Microbial-Derived Toll-like Receptor Agonism in Cancer Treatment and Progression by Eileena F. Giurini, Mary Beth Madonna, Andrew Zloza, Kajal H. Gupta

Get full text

Impact of advanced prostatic cancer treatment on quality of life and sexual function by Fernando Parma Marsicano, Andy Petroianu

“…INTRODUCTION: The studying the quality of life after cancer treatment has become a priority in oncology. Objectives: To evaluate the impact of different treatments for recurrence prostate cancer on quality of life and sexual activity. …”
Get full text

Interfering with the Ubiquitin-Mediated Regulation of Akt as a Strategy for Cancer Treatment by Elena Paccosi, Alessio Balzerano, Luca Proietti-De-Santis

“…Recent evidence indicates that targeting the ubiquitin proteasome system is effective for certain cancer treatments. In this review, the functions and roles of Akt in human cancer will be discussed, with a main focus on molecules and compounds that target various elements of the ubiquitination processes that regulate the activation and inactivation of Akt. …”
Get full text

Cancer treatment-related financial toxicity in Japan: a scoping review by Yuki Itani, Kyoko Obama, Maiko Fujimori, Junko Saito, Yosuke Uchitomi

Subjects: “…cancer treatment…”
Get full text

Recent Advances in Drug Discovery for Triple-Negative Breast Cancer Treatment by Domiziana Masci, Chiara Naro, Michela Puxeddu, Andrea Urbani, Claudio Sette, Giuseppe La Regina, Romano Silvestri

Get full text

Transforming the landscape of colorectal cancer treatment with immunotherapy: Evolution and future horizons by Jan Clerick, Aude Van Oosterwyck, Saskia Carton

“…Cancer Treatment and Research Communications…”
Get full text

Lipid-Nucleic Acid Complexes: Physicochemical Aspects and Prospects for Cancer Treatment by Ricardo Gaspar, Filipe Coelho, Bruno F. B. Silva

“…In this review, we attempt to cover the most important biophysical and physicochemical aspects of non-viral lipid-based gene therapy formulations, with a perspective on future cancer treatments in mind.…”
Get full text

New hopes for the breast cancer treatment: perspectives on the oncolytic virus therapy by Hanna Chowaniec, Antonina Ślubowska, Magdalena Mroczek, Martyna Borowczyk, Małgorzata Braszka, Grzegorz Dworacki, Grzegorz Dworacki, Paula Dobosz, Paula Dobosz, Mateusz Wichtowski

“…Several OVs have been studied for breast cancer treatment, including adenovirus, protoparvovirus, vaccinia virus, reovirus, and herpes simplex virus type I (HSV-1). …”
Get full text

Applications of phase change materials in smart drug delivery for cancer treatment by Jianfeng Bao, Hui Tu, Jing Li, Yijia Li, Shan Yu, Jingpi Gao, Kun Lei, Fengshou Zhang, Jinghua Li

Get full text

Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment by Meng Yuan, Yirui Zhai, Zhouguang Hui

“…How to further optimize the combination of radiotherapy and immunotherapy is among the current hot topics in cancer treatment. In addition to adopting the preferred dose-fractionation of radiotherapy or the regimen of immunotherapy, it is also very promising to add antiangiogenic therapy to this combination. …”
Get full text

Combination of Nanomaterials in Cell-Based Drug Delivery Systems for Cancer Treatment by Lu Tang, Shun He, Yue Yin, Hening Liu, Jingyi Hu, Jie Cheng, Wei Wang

Subjects: Get full text

Assessment of Two Commercial Comprehensive Gene Panels for Personalized Cancer Treatment by Anine Larsen Ottestad, Mo Huang, Elisabeth Fritzke Emdal, Robin Mjelle, Veronica Skarpeteig, Hong Yan Dai

“…A proportion of 14/19 (74%) samples were classified in the same TMB category; (4) Conclusions: Comparable results were obtained using OCAP and TSO500, suggesting that both panels could be applied to screen patients for enrolment in personalized cancer treatment trials.…”
Get full text